The induced pluripotent stem cell (iPSC) production platform at the CRCHU de Québec specializes in reprogramming somatic cells into iPSCs from various sources such as skin, blood, urine, etc. It also offers training opportunities for the culture and utilization of these cells. With over 200 reprogramming cases completed, the iPSC platform is capable of delivering high-quality services at competitive prices to all academic researchers at the CHU de Québec-Université Laval Research Center and throughout the province of Quebec. Its services are also available to researchers from other provinces and countries.
In summary:
- Operational since 2015
- Over 200 iPSC lines produced
- Extensive expertise in isolating cells from urine, skin biopsies, and blood
- The first platform of its kind in Quebec, which has become a provincial platform thanks to a grant from the Quebec Ministry of Economy and Innovation in 2019.
- Customized services